CLINICAL_TRIALS ClinicalTrials.gov record update

Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Multicentric Castleman's Disease: a Prospective, Single-center, Single-arm, Phase-II Pilot Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03043105
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:44.389397+00:00
Published At: 2020-04-16T00:00:00+00:00
Record Updated At: 2020-04-16
Results Posted At: 2020-04-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Multicentric Castleman Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-04-16"
protocolSection.identificationModule.nctId: "NCT03043105"
protocolSection.identificationModule.officialTitle: "Thalidomide, Cyclophosphamide and Prednisone in Newly Diagnosed Multicentric Castleman\u0027s Disease: a Prospective, Single-center, Single-arm, Phase-II Pilot Trial"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-04-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.